Summit Therapeutics SMMT
NASDAQ SMMT
$16.40 +0.92 (+5.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Return on Equity [ROE] (2018 - 2024)

Updated

Summit Therapeutics (SMMT) recorded Return on Equity [ROE] of -56.78% in Q4 2024, up 631.82 percentage points from -688.59% a year earlier and up 8.08 percentage points from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Return on Equity [ROE] (2018 - 2024) Analysis & Trends

For FY2024, Summit Therapeutics reported Return on Equity [ROE] of -100.63%, up 501.22 percentage points from FY2023.

  • Annual Return on Equity [ROE] has a five-year change of -59.06 percentage points (FY2019 to FY2024).
  • Across earlier years, Return on Equity [ROE] came in at -601.85% in FY2023 (-526.80 pp), -75.05% in FY2022 (+33.84 pp), -108.89% in FY2021 (-42.32 pp) and -66.57% in FY2020 (-25.00 pp).
  • The Q4 2024 figure is the highest quarterly Return on Equity [ROE] since Q4 2022.
  • On a year-over-year basis, Return on Equity [ROE] has increased for four consecutive quarters, with an average year-over-year change of -5.61 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 631.82 percentage points in Q4 2024, against a drop of 633.12 percentage points in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -64.86% (Q3 2024), -137.85% (Q2 2024) and -193.61% (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.32%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 7.21%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 84.40%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 21.39%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.75%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -18.38%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 22.24%
10 Summit Therapeutics 12.28 Bn 10.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -56.78%
Sep 30, 2024 -64.86%
Jun 30, 2024 -137.85%
Mar 31, 2024 -193.61%
Dec 31, 2023 -688.59%
Sep 30, 2023 -542.28%
Jun 30, 2023 -466.40%
Mar 31, 2023 -451.37%
Dec 31, 2022 -55.47%
Sep 30, 2022 -85.49%
Jun 30, 2022 -140.94%
Mar 31, 2022 -126.31%
Dec 31, 2021 -95.49%
Sep 30, 2021 -67.69%
Jun 30, 2021 -79.62%
Mar 31, 2021 -89.05%
Dec 31, 2020 -90.95%
Sep 30, 2020 -103.53%
Jun 30, 2020 -61.94%
Mar 31, 2020 -39.97%
API Access

Summit Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SMMT&period=max&api_key=YOUR_API_KEY